As shown in Fig. 3A and B, NeuN immunoreactivity appears decreased, verified by significant decrease in both STR and CTX to similar levels across all HD pathological staging (Fig. 3F), whereas GFAP levels trended up in the STR, but were relatively stable in the CTX (Fig. 3A, B, F). Here, RBFOX3 is linked to Huntington disease.